Latab, Nanie S.

HRN: 13-82-23  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2023
CEFTAZIDIME 1GM (VIAL)
12/03/2023
12/10/2023
IV
1 Gram
Q8H
CAP MR; T/C TB Bronchiectasis
Waiting Final Action 
12/04/2023
CLARITHROMYCIN 500MG (CAP)
12/04/2023
12/11/2023
PO
500mg
BID
Cap-MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: